<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Cellular fibronectin is an endothelium-derived protein involved in subendothelial matrix assembly </plain></SENT>
<SENT sid="1" pm="."><plain>Elevated plasma levels of cellular fibronectin therefore reflect loss of endothelial cell polarization or injury to blood vessels </plain></SENT>
<SENT sid="2" pm="."><plain>Consequently, elevated plasma levels of circulating cellular fibronectin have been described in clinical syndromes with vascular damage, although not in <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: We determined fibronectin levels in 52 patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, 50 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 54 patients with a history of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, 23 patients with <z:hpo ids='HP_0001920'>renal artery stenosis</z:hpo>, and 64 healthy subjects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Circulating cellular fibronectin was significantly elevated in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> (4.3 +/- 2.8 microg/ml) compared with patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (2.0 +/- 0.9 microg/ml), patients with <z:hpo ids='HP_0100817'>renovascular hypertension</z:hpo> (1.7 +/- 1.1 microg/ml), and healthy subjects (1.4 +/- 0.6 microg/ml) </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with <z:mp ids='MP_0002055'>diabetes</z:mp> and at least one <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> had an almost 2.5-fold increase in cellular fibronectin compared with diabetic subjects without such a risk factor </plain></SENT>
<SENT sid="6" pm="."><plain>In multivariate regression analysis, higher <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, current or past cigarette smoking, and higher urinary albumin excretion were independently associated with an increase in circulating cellular fibronectin in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results suggest that circulating cellular fibronectin may be a marker protein for endothelial cell activation, especially in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Prospective studies are needed to explore this possibility </plain></SENT>
</text></document>